PETALING JAYA: IHH Healthcare Bhd
remains confident in its growth trajectory underpinned by strong clinical capabilities amid rising demand.
For the second quarter ended June 30, 2026 (2Q26), the healthcare provider’s net profit surged by 29% year-on-year (y-o-y) to RM573mil or earnings per share of 6.48 sen. This was on the back of higher revenue, offset by higher staff cost and other operating expenses.
Revenue is up by 12% y-o-y to RM7.05bil. The group said the growth in revenue was driven by a sustained demand for quality healthcare services, a case-mix of more acute patients and price adjustments to counter inflation.
It noted that the consolidation of Bayindir Healthcare, TMI Healthcare and Biruni Labs, which were acquired after 2Q25, also contributed to the increase in revenue.
In a filing with Bursa Malaysia, IHH said the Singapore hospital’s 2Q26 inpatient admissions decreased by 6% y-o-y, while revenue per inpatient admission increased 1% y-o-y. The company said the decrease is attributed to structural shifts towards public healthcare utilisation, and compounded by Middle East tensions that have dampened demand from medical tourism.
IHH said its operations in Singapore stayed on track for recovery in 2H26 as guided with occupancy picking up from 1Q lows to 51% in 2Q with strong margins of 29%.
For its Malaysia hospital, IHH said 2Q26 inpatient admissions increased by 3% y-o-y, while revenue per inpatient admission increased by 16% y-o-y.
Meanwhile, the India hospital’s 2Q26 inpatient admissions increased by 14% y-o-y, while revenue per inpatient admission increased by 5% y-o-y.
The group added that the Turkiye and Europe hospital 2Q26 inpatient admissions increased by 15% y-o-y, while revenue per inpatient admission increased by 22% y-o-y with price adjustments, especially in Turkiye, to counter hyperinflation.
For the first half of the year ended Dec 31, 2026, net profit rose by 15% y-o-y to RM1.1bil or earnings per share of 12.46 sen.
Revenue for the period expanded by 8% y-o-y to RM13.6bil.
IHH declared an interim single tier cash dividend of 5.5 sen per ordinary share for FY26.
